Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 1/20 | 0.52 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | THRB | P10828 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.48 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.46 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.42 |
| ▸ | FDPS | P14324 | 3/20 | 0.42 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.42 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.42 |
| ▸ | CES2 | O00748 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31306911 | 1.00 | MAPT (0.52) | MAPTTSHRTHRBLMNADNM1 | |
| SCHEMBL7565480 | 1.00 | MAPT (0.52) | MAPTTSHRTHRBLMNADNM1 | |
| SCHEMBL19026469 | 1.00 | MAPT (0.52) | MAPTTSHRTHRBLMNADNM1 | |
| SCHEMBL10608053 | 1.00 | MAPT (0.52) | MAPTTSHRTHRBLMNADNM1 | |
| SCHEMBL16135675 | 1.00 | MAPT (0.52) | MAPTTSHRTHRBLMNADNM1 | |
| SCHEMBL24926247 | 1.00 | MAPT (0.52) | MAPTTSHRTHRBLMNADNM1 | |
| SCHEMBL18725210 | 1.00 | MAPT (0.52) | MAPTTSHRTHRBLMNADNM1 | |
| SCHEMBL19853017 | 1.00 | MAPT (0.52) | MAPTTSHRTHRBLMNADNM1 | |
| SCHEMBL8173118 | 1.00 | MAPT (0.52) | MAPTTSHRTHRBLMNADNM1 | |
| SCHEMBL31203879 | 1.00 | MAPT (0.52) | MAPTTSHRTHRBLMNADNM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 58 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118662440-A | Composition of fluorocarbon nano emulsion, preparation method and application thereof | 努沃克斯制药有限责任公司 | 2024-09-20 | — | — | CN | claimed |
| EP-2652753-B1 | DIELECTRIC INSULATION MEDIUM | ABB TECHNOLOGY AG (CH) | 2015-08-26 | — | — | EP | claimed |
| EP-2652751-B1 | DIELECTRIC INSULATION MEDIUM | ABB RESEARCH LTD (CH) | 2015-02-25 | — | — | EP | claimed |
| US-8709303-B2 | Dielectric insulation medium | ABB RESEARCH LTD. (CH) | 2014-04-29 | — | — | US | claimed |
| EP-2652753-A1 | DIELECTRIC INSULATION MEDIUM | ABB Technology AG (CH) | 2013-10-23 | — | — | EP | claimed |
| EP-2652751-A1 | DIELECTRIC INSULATION MEDIUM | ABB Research Ltd. (CH) | 2013-10-23 | — | — | EP | claimed |
| US-20130265692-A1 | Dielectric Insulation Medium | ABB RESEARCH LTD. (CH) | 2013-10-10 | — | — | US | claimed |
| US-20130221292-A1 | Dielectric Insulation Medium | ABB TECHNOLOGY AG (CH) | 2013-08-29 | — | — | US | claimed |
| WO-2012080222-A1 | DIELECTRIC INSULATION MEDIUM | ABB RESEARCH LTD (CH) | 2012-06-21 | — | — | WO | claimed |
| WO-2012080269-A1 | DIELECTRIC INSULATION MEDIUM | ABB TECHNOLOGY AG (CH) | 2012-06-21 | — | — | WO | claimed |
| CN-116323272-B | Thermal conditioning of batteries by immersion in liquid compositions | 阿科玛法国公司 | 2026-05-19 | — | — | CN | disclosed |
| CN-119345149-A | Preparation method and application of cell membrane modified ultrasonic response type copper/iron death activation nano-carrier | 南京大学 | 2025-01-24 | — | — | CN | disclosed |
| CN-119139530-B | Dressing for diabetic foot wound surface and preparation method thereof | 南方医科大学南方医院 | 2025-01-14 | — | — | CN | disclosed |
| CN-119139530-A | Dressing for diabetic foot wound surface and preparation method thereof | 南方医科大学南方医院 | 2024-12-17 | — | — | CN | disclosed |
| CN-118973549-A | Compositions suitable for high oil content | 莱雅公司 | 2024-11-15 | — | — | CN | disclosed |
| WO-2012080222-A1 | DIELECTRIC INSULATION MEDIUM | ABB RESEARCH LTD (CH) | 2012-06-21 | — | — | WO | disclosed |
| US-20020077368-A1 | Use of fluorocarbons for diagnosis and treatment of articular disorders | WALTERS MARK A (US) | 2002-06-20 | — | — | US | disclosed |
| US-6368613-B1 | ANTIINFLAMMATORY AGENTS; IN SITU ADMINISTERING | ALLIANCE PHARMACEUTICAL CORP. | 2002-04-09 | — | — | US | disclosed |
| US-5861175-A | ADMINISTERING FOR CUSHIONING AND LUBRICATION OF JOINTS; ARTHRIRIS, RHEUMATIC DISEASES | ALLIANCE PHARMACEUTICAL CORP. (US) | 1999-01-19 | — | — | US | disclosed |
| WO-1997033563-A2 | FLUOROCARBONS FOR DIAGNOSIS AND TREATMENT OF ARTICULAR DISORDERS | ALLIANCE PHARMACEUTICAL CORP. (US) | 1997-09-18 | — | — | WO | disclosed |